Veldhuis J D, Strauss J F, Silavin S L, Kolp L A
Endocrinology. 1985 Jan;116(1):25-30. doi: 10.1210/endo-116-1-25.
We have used a novel competitive inhibitor of acyl coenzyme A:cholesterol acyltransferase (ACAT), Sandoz compound 58-035 [3-(decyldimethyl-silyl)N-[2-(4-methyl-phenyl)1-phenylethyl propanamide], to assess the importance of the cholesterol esterification reaction in ovarian steroidogenesis. Compound 58-035 markedly (greater than or equal to 96%) inhibited ACAT activity of swine ovarian microsomes in a dose-dependent (0.1-3.5 micrograms/ml) fashion. In addition, treatment of cultured granulosa cells with this fatty acylamide effectively (greater than or equal to 98%) suppressed hormonally stimulated cholesterol esterification, as assessed by the incorporation of [3H]oleic acid into cholesteryl ester. Accordingly, we used this inhibitor to test the role of cholesterol esterification in ovarian cells. In cultures with limited or no serum supplementation, long term (2- to 6-day) treatment of granulosa cells with compound 58-035 significantly increased basal progesterone production and amplified by 2- to 10-fold the stimulatory actions of trophic hormones, such as estradiol, FSH, estradiol combined with FSH, or insulin. The amplifying effect of ACAT inhibition on hormone-stimulated progesterone production could be mimicked by providing exogenous cholesterol substrate in the form of low density lipoprotein (LDL). Cotreatment with compound 58-035 and LDL resulted in no further augmentation of steroidogenesis. In contrast to the facilitative effects of compound 58-035 in longer term cultures, this ACAT inhibitor did not alter progesterone biosynthesis acutely (2-20 h) in swine or hamster ovarian cells. These observations suggest that there is an obligatory partitioning of some sterol into the ester pool in granulosa cells. In times of diminished availability of cholesterol, inhibition of the esterification pathway can make additional cholesterol available for use in steroid hormone biosynthesis. Thus, in the intact Graafian follicle, where LDL cholesterol delivery to granulosa cells and intracellular cholesteryl ester stores are limited, regulation of the ACAT reaction may significantly modulate rates of progesterone biosynthesis. The present results indicate that the use of a selective inhibitor of cholesterol esterification can permit one to probe the functional significance of the esterification reaction in steroidogenic cells.
我们使用了一种新型的酰基辅酶A:胆固醇酰基转移酶(ACAT)竞争性抑制剂,即山德士化合物58 - 035 [3 -(癸基二甲基甲硅烷基)-N - [2 -(4 - 甲基苯基)-1 - 苯乙基]丙酰胺],来评估胆固醇酯化反应在卵巢类固醇生成中的重要性。化合物58 - 035以剂量依赖性方式(0.1 - 3.5微克/毫升)显著(大于或等于96%)抑制猪卵巢微粒体的ACAT活性。此外,用这种脂肪酰胺处理培养的颗粒细胞有效地(大于或等于98%)抑制了激素刺激的胆固醇酯化,这通过将[3H]油酸掺入胆固醇酯中来评估。因此,我们使用这种抑制剂来测试胆固醇酯化在卵巢细胞中的作用。在血清补充有限或无血清补充的培养物中,用化合物58 - 035对颗粒细胞进行长期(2至6天)处理显著增加了基础孕酮的产生,并将诸如雌二醇、促卵泡激素、雌二醇与促卵泡激素联合或胰岛素等促性腺激素的刺激作用放大了2至10倍。通过以低密度脂蛋白(LDL)形式提供外源性胆固醇底物,可以模拟ACAT抑制对激素刺激的孕酮产生的放大作用。用化合物58 - 035和LDL共同处理不会导致类固醇生成的进一步增加。与化合物58 - 035在长期培养中的促进作用相反,这种ACAT抑制剂在猪或仓鼠卵巢细胞中不会急性(2至20小时)改变孕酮的生物合成。这些观察结果表明,在颗粒细胞中存在一些固醇必然会分配到酯池中。在胆固醇可用性降低的时候,抑制酯化途径可以使额外的胆固醇可用于类固醇激素的生物合成。因此,在完整的格拉夫卵泡中,由于LDL胆固醇向颗粒细胞的递送以及细胞内胆固醇酯储存有限,ACAT反应的调节可能会显著调节孕酮生物合成的速率。目前的结果表明,使用胆固醇酯化的选择性抑制剂可以使人们探究酯化反应在类固醇生成细胞中的功能意义。